NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

Cover of Drugs and Lactation Database (LactMed)

Drugs and Lactation Database (LactMed) [Internet].

Show details

Rabeprazole

Last Revision: June 3, 2019.

Estimated reading time: 1 minute

CASRN: 117976-89-3

Chemical structure

Drug Levels and Effects

Summary of Use during Lactation

Because no information is available on the use of rabeprazole during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

A retrospective claims database study in the United States found that users of proton pump inhibitors had an increased risk of gynecomastia.[1]

The Spanish pharmacovigilance system found one case of a 90-year-old man who developed gynecomastia associated with rabeprazole reported during the time period of 1982 to 2006. The reaction occurred after 32 days of therapy and resolved after discontinuation of the drug.[2]

References

1.
Carvajal A, Macias D, Gutierrez A et al. Gynaecomastia associated with proton pump inhibitors: A case series from the Spanish Pharmacovigilance System. Drug Saf. 2007;30:527-31. [PubMed: 17536878]

Substance Identification

Substance Name

Rabeprazole

CAS Registry Number

117976-89-3

Drug Class

  • Breast Feeding
  • Anti-Ulcer Agents
  • Gastrointestinal Agents
  • Proton Pump Inhibitors

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Views

Related information

Similar articles in PubMed

  • Identification and characterization of potential impurities of rabeprazole sodium.[J Pharm Biomed Anal. 2007]
    Identification and characterization of potential impurities of rabeprazole sodium.
    Reddy GM, Bhaskar BV, Reddy PP, Sudhakar P, Babu JM, Vyas K, Reddy PR, Mukkanti K. J Pharm Biomed Anal. 2007 Mar 12; 43(4):1262-9. Epub 2006 Nov 28.
  • Review Lansoprazole[Drugs and Lactation Database (...]
    Review Lansoprazole
    . Drugs and Lactation Database (LactMed). 2006
  • Review Pantoprazole[Drugs and Lactation Database (...]
    Review Pantoprazole
    . Drugs and Lactation Database (LactMed). 2006
  • Review Dexlansoprazole[Drugs and Lactation Database (...]
    Review Dexlansoprazole
    . Drugs and Lactation Database (LactMed). 2006
  • Review Pioglitazone[Drugs and Lactation Database (...]
    Review Pioglitazone
    . Drugs and Lactation Database (LactMed). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...